FDA declines to regulate CBD; calls on Congress for fix
- The Food and Drug Administration said 1/26/23 there are too many unknowns about CBD products to regulate them as foods or supplements and called on Congress to create new rules for the massive and growing market.
- Questions remain about CBD’s effects on liver, male reproductive system and on pregnant women and children.
- New rules could include clear labels, regulations regarding contaminants, limits on CBD levels and requirements, such as a minimum purchase age. Regulations are also needed for CBD products for animals.
- The FDA will continue to take action against CBD and other cannabis products to protect the public. The agency has sent warning letters to some companies making health claims for CBD. Go to AP News click here.